戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 activity when the phenyl substituent was 3,4-dichloro.
2 ngation factor-b (P-TEFb) inhibitor DRB (5,6-dichloro 1-beta-d-ribofuranosylbenzinida-sole).
3 tion of a disulfide bond by oxidization with dichloro(1,10-phenanthroline)copper (II) (CuPh), or the
4 cy of a series of metallopeptides containing dichloro(1,10-phenanthroline)copper(II) and various orga
5 gs, such as bruceantin and LY2109761, and 2) dichloro(1,2-diaminocyclohexane)platinum(II) (DachPt).
6  ruthenacyclobutanes via the protonolysis of dichloro(1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinyl
7 mino)-2,2-dinitroethyl}diazene) (10), N1, N2-dichloro-1, 2-diazenedicarboximidamide (11), and (E,E)-N
8   2-Amino-N'-arylbenzamidines react with 4,5-dichloro-1,2,3-dithiazolium chloride (Appel salt) in the
9 -bromo-1,2-bis(trimethylsilyl)benzene or 4,5-dichloro-1,2-bis(trimethylsilyl)benzene with BBr3 in hex
10 rides occurs rapidly upon treatment with 3,3-dichloro-1,2-diphenylcyclopropene.
11 samples from 10 swimming pools and found 2,6-dichloro-1,4-benzoquinone (2,6-DCBQ) in all the pools at
12 o-3-methyl-1,4-benzoquinone (DCMBQ), and 2,6-dichloro-1,4-benzoquinone (DBBQ), were treated using a m
13 using formation potential (FP) tests for 2,6-dichloro-1,4-benzoquinone (DCBQ), 2,3,6-trichloro-1,4-be
14      Water samples containing four HBQs, 2,6-dichloro-1,4-benzoquinone (DCBQ), 2,3,6-trichloro-1,4-be
15           Four halobenzoquinones (HBQs), 2,6-dichloro-1,4-benzoquinone (DCBQ), 2,6-dichloro-3-methyl-
16  four HBQs were identified as 3-hydroxyl-2,6-dichloro-1,4-benzoquinone (OH-DCBQ) from DCBQ, 5-hydroxy
17 ,6-trichlorophenol (TCP) is converted to 2,6-dichloro-1,4-benzoquinone in a H2O2-dependent process.
18 of an electron-deficient reagent such as 2,6-dichloro-1,4-benzoquinone suppressed this isomerization
19 (2) will fully convert 1 equiv of TCP to 2,6-dichloro-1,4-benzoquinone, implicating the role of multi
20 -dibromo-1,4-benzoquinone or 2,5-diamino-3,6-dichloro-1,4-benzoquinone, proceeding through single-cry
21 to form 2,6-dibromo-1,4-benzoquinone and 2,6-dichloro-1,4-benzoquinone, respectively.
22 ave obtained a compound (5,8-diacetyloxy-2,3-dichloro-1,4-naphthoquinone) that provokes IR activation
23 ichlorocarbene to bicyclobutane to yield 1,1-dichloro-1,4-pentadiene.
24 ranosyl)benzimidazole (TCRB) and 2-bromo-5,6-dichloro-1-(beta-d-ribofuranosyl)benzimidazole (BDCRB) a
25     Amino acid ester prodrugs of 2-bromo-5,6-dichloro-1-(beta-d-ribofuranosyl)benzimidazole (BDCRB) w
26  the DNA encapsidation inhibitor 2-bromo-5,6-dichloro-1-(beta-d-ribofuranosyl)benzimidazole.
27 ching equilibrium with the carbinolamine 2,2-dichloro-1-(chloroamino)ethanol ( K(1) = 1.87 x 10(4) M(
28                                    Then, 2,2-dichloro-1-(chloroamino)ethanol underwent two parallel r
29 in-3-yl)-N'-cyanoguanidines furnished N-{2,2-dichloro-1-[N'-(substituted-pyridin-3-yl)-N''-cyanoguani
30 kinase and mRNA synthesis inhibitor DRB (5,6-dichloro-1-b-D-ribofuranosylbenzimidazole) induces the n
31 nslocation inhibitors alpha amanitin and 5,6-dichloro-1-beta-D-ribobenzimidazole (DRB) and an siRNA t
32               Treatment of neurons with 5, 6-dichloro-1-beta-D-ribobenzimidazole (DRB), an RNA Pol II
33 equires for activity the two-polypeptide 5,6-dichloro-1-beta-D-ribobenzimidazole-sensitivity inducing
34 th the viral terminase inhibitor 2-bromo-5,6-dichloro-1-beta-d-ribofuranosyl benzimidazole riboside (
35 r herpesvirus genome maturation, 2-bromo-5,6-dichloro-1-beta-d-ribofuranosyl benzimidazole riboside (
36 (ii) DB particles recovered from 2-bromo-5,6-dichloro-1-beta-d-ribofuranosyl benzimidazole riboside (
37 ption of transcription by actinomycin D, 5,6-dichloro-1-beta-D-ribofuranosyl-benzimadazole or alpha-a
38 ments with two CKII-specific inhibitors, 5,6-dichloro-1-beta-d-ribofuranosyl-benzimidazole (DRB) and
39  Inhibition of P-TEFb kinase activity by 5,6-dichloro-1-beta-d-ribofuranosyl-benzimidazole (DRB) supp
40                             Furthermore, 5,6-dichloro-1-beta-d-ribofuranosyl-benzimidazole, an inhibi
41  However, CTD kinase inhibitors, such as 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB) and 1
42 rase II (Pol II) hyperphosphorylation by 5,6-dichloro-1-beta-d-ribofuranosylbenzimidazole (DRB) block
43             The selective CK2 inhibitors 5,6-dichloro-1-beta-d-ribofuranosylbenzimidazole (DRB) or 4,
44 of negative elongation factor (NELF) and 5,6-dichloro-1-beta-d-ribofuranosylbenzimidazole (DRB) sensi
45 ls or an extract is no longer sensitive to 6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB), a co
46 uding the CDK9 pharmacological inhibitor 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB), a do
47  first, infected cells were treated with 5,6-dichloro-1-beta-d-ribofuranosylbenzimidazole (DRB), a sp
48                Here, we demonstrate that 5,6-dichloro-1-beta-d-ribofuranosylbenzimidazole (DRB), an i
49 ors on HDV genome replication: amanitin, 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB), and
50 ibition of transcription elongation with 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB), comb
51 n of U0126, the mRNA synthesis inhibitor 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB), or i
52 stein (a tyrosine kinase inhibitor), and 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB, a CK2
53 s well as by the gene expression blocker 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole administere
54 her serum-responsive factor knockdown or 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole altered rec
55           Inhibition of CKII activity by 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole blocks the
56 scriptionally active, as incubation with 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole eliminated
57 tment with the casein kinase 2 inhibitor 5,6-dichloro-1-beta-d-ribofuranosylbenzimidazole had the opp
58  and by the inhibitor of gene expression 5,6-dichloro-1-beta-d-ribofuranosylbenzimidazole infused imm
59 ting this view, we found synergy between 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole riboside an
60    Negative elongation factor (NELF) and 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole sensitivity
61 he cdk9 inhibitors Flavopiridol and DRB (5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole) allowed cd
62 to the well-known nucleoside analog DRB (5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole), and that
63 th CTD kinase inhibitors, including DRB (5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole), causes a
64 ycin, a tyrosine kinase inhibitor and by 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole, a protein
65 ent with a nonspecific kinase inhibitor, 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole.
66 ow concentrations of the CDK9 inhibitor 5, 6-dichloro-1-beta-D-ribofuranosylbenzimidazole.
67 alogenated benzimidazoles BDCRB (2-bromo-5,6-dichloro-1-beta-D-riborfuranosyl benzimidazole riboside)
68              Epoxide 2 was prepared from 3,4-dichloro-1-butene (1) by epoxidation with m-CPBA and sub
69 ics of the unimolecular rearrangement of 2,2-dichloro-1-methylenecyclopropane (1) to (dichloromethyle
70  We present a novel class of substituted 7,8-dichloro-1-oxo-beta-carbolines based on the distinct str
71 as synthesized by potassium reduction of 1,1-dichloro-1-silafluorene in refluxing THF.
72 lowing: 2,8-dichlorodibenzodioxin (4%), 4,5'-dichloro-[1,1'-biphenyl]-2,2'-diol (10%), 5-chloro-2-(4-
73 phosphorylation by the kinase inhibitors 5,6-dichloro-1beta-D-ribofuranosyl-benzimidazole and H8 bloc
74 aphtho[1,2-d]thiazol-2-ylamine (SKA-31), 6,7-dichloro-1H-indole-2,3-dione 3-oxime (NS309), and 1-ethy
75 imes more potent on K(Ca)2.1 than NS309 (6,7-dichloro-1H-indole-2,3-dione 3-oxime), an unselective bu
76          (E)-3-(2-Carboxy-2-phenylvinyl)-4,6-dichloro-1H-indole-2-carboxylic acid, 1, is a potent and
77  of 3-[2-(3-aminophenyl)-2-carboxyvinyl]-4,6-dichloro-1H-indole-2-carboxylic acid, 19, as a new poten
78 ll molecule agonist MDL29,951 (2-carboxy-4,6-dichloro-1H-indole-3-propionic acid) decreases myelin ba
79 the preparation of the fluorescent dye 4',5'-dichloro-2',7'-dimethoxy-5(6)-carboxyfluorescein (JOE) i
80        A series of methoxyl-substituted 3,3'-dichloro-2,2'-binaphthoquinones 2 were prepared and eval
81 ine (dmb, 2), 2,2'-bipyridine (bpy, 3), 4,4'-dichloro-2,2'-bipyridine (dclb, 4), and 4,4'-diethyleste
82  oxidase (BOD) "wired" with PAA-PVI-[Os(4,4'-dichloro-2,2'-bipyridine)(2)Cl](+/2+) (polymer II), havi
83  (N-vinylimidazole) complexed with [Os (4,4'-dichloro-2,2'-bipyridine)(2)Cl](+/2+), cross-linked on c
84  found with polychlorinated biphenyl or 1,1'-dichloro-2,2'-bis(4-chlorophenyl)ethylene levels and any
85 lyzed for polychlorinated biphenyls and 1,1'-dichloro-2,2'-bis(4-chlorophenyl)ethylene.
86     A novel class of pure antiestrogens, 1,1-dichloro-2,2,3-triarylcyclopropanes (DTACs), lack estrog
87 ons of polychlorinated biphenyl (PCB)-153; 1-dichloro-2,2-bis (p-chlorophenyl) ethylene (p,p'-DDE), a
88 ophenyl)ethane (DDT) and its metabolites 1,1-dichloro-2,2-bis(4-chlorophenyl)ethane (DDD) and 1,1-dic
89 -2,2-bis(4-chlorophenyl)ethane (DDD) and 1,1-dichloro-2,2-bis(4-chlorophenyl)ethylene (DDE), are ofte
90 potential of the antiandrogen, p,p -DDE [1,1-dichloro-2,2-bis(p-chlorophenyl) ethylene], the most pre
91 l)ethane] and its metabolites, 4,4'-DDD [1,1-dichloro-2,2-bis(p-chlorophenyl)ethane] and 4,4'-DDE [1,
92                                          1,1-Dichloro-2,2-bis(p-chlorophenyl)ethylene (DDE), a persis
93   The main degradation product of DDT is 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene (DDE), an antia
94 transformers and other applications, and 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene (DDE), the main
95 e to persistent organochlorines such as 1,1,-dichloro-2,2-bis(p-chlorophenyl)ethylene (p,p -DDE), pol
96                                          1,1-Dichloro-2,2-bis(p-chlorophenyl)ethylene (p,p'-DDE) is a
97 t relating polychlorinated biphenyls and 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene to time to preg
98 CBs (polychlorinated biphenyls) and DDE [1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene] reduces 6-mont
99 bis(p-chlorophenyl)ethane] and 4,4'-DDE [1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene], from an histo
100 ic assay for the determination of DDT [1,1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene].
101                        WAY-161503 ((4aR)-8,9-dichloro-2,3,4,4a-tetrahydro-1H-pyrazino[1,2-a]quinoxali
102 ithio-2,3,4,5-tetraphenylsilole (1) with 1,1-dichloro-2,3-diphenylcyclopropene (2) leads to the novel
103  deprotonated 2-oxa-6-azaadamantane with 2,6-dichloro-2,6-diazaadamantane.
104 yl)propyl)thio)benzoic acid (GRI977143), 4,5-dichloro-2-((9-oxo-9H-fluoren-2-yl)carbamoyl)benzoic aci
105 tions where, (1) it slowly dehydrated to 1,1-dichloro-2-(chloroimino)ethane ( k(2) = 1.09 x 10(-5) s(
106 logii, net CO(2) fixation was blocked by 3,3-dichloro-2-(dihydroxyphosphinoyl-methyl)-propenoate (a s
107 onse to its estrogenic isomer, o,p -DDE [1,1-dichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl) ethylene]
108 epared from commercially available trans-1,4-dichloro-2-butene were converted to trans-disubstituted
109 e have previously shown that 4-(2-butyl-6, 7-dichloro-2-cyclopentyl-indan-1-on-5-yl) oxobutyric acid
110                               4-(2-Butyl-6,7-dichloro-2-cyclopentyl-indan-1-on-5-yl) oxobutyric acid
111 phoenolpyruvate carboxylase (PEPCase) by 3,3-dichloro-2-dihydroxyphosphinoylmethyl-2-propenoate resul
112                                       In 3,3-dichloro-2-dihydroxyphosphinoylmethyl-2-propenoate-treat
113                                     Tris(1,3-dichloro-2-isopropyl) phosphate (TDCIPP) concentrations
114 loroisopropyl) phosphate (TCPP) and tris(1,3-dichloro-2-isopropyl) phosphate (TDCP)), four alkylated
115                                 Dicamba (3,6-dichloro-2-methoxybenzoic acid) is a widely used herbici
116 around aryl sulfonamide series led to N-(3,5-dichloro-2-methoxyphenyl)-3-(1-methylpiperidin-4-ylamino
117 nduced by our hit fragment compared with 4,6-dichloro-2-methyl-3-aminoethyl-indole (DCAI), a Ras liga
118 -(1,1-dimethylethyl)-3-(methylsulfonyl)-,6,7-dichloro-2-methylsulfonyl-3-N-tert-butylaminoquinoxaline
119 ell as small molecule allosteric agonist 6,7-dichloro-2-methylsulfonyl-3-tert-butylaminoquinoxaline (
120 ide (Z)-6-O-(tert-butyldimethylsilyl)-1-(4,5-dichloro-2-nitrophenyl)-1,2-dideo xy-3,4-O-isopropyliden
121 ride, 2,4-dichloroaniline, and sea-nine (4,5-dichloro-2-octyl-3-isothiazolone)).
122                All four diastereomers of 3,4-dichloro-2-pentanol were synthesized by anti-dichlorinat
123 of 3-chloropropane-1,2-diol (3-MCPD) and 1,3-dichloro-2-propanol (1,3-DCP) were found in domestically
124 -2-ethylhexyl phosphate (TEHP), and tris-1,3-dichloro-2-propyl phosphate (TDCPP) were coated on (NH4)
125         TDCIPP and TPHP metabolites (bis(1,3-dichloro-2-propyl) phosphate (BDCIPP) and diphenyl phosp
126 The current study measured levels of bis(1,3-dichloro-2-propyl) phosphate (BDCIPP), bis(1-chloro-2-pr
127 asured five urinary PFR metabolites [bis(1,3-dichloro-2-propyl) phosphate (BDCIPP), diphenyl phosphat
128 ponding to maxima dust for the pairs bis(1,3-dichloro-2-propyl) phosphate (BDCIPP)-tris(1,3-dichloro-
129  course of 3 months and analyzed for bis(1,3-dichloro-2-propyl) phosphate (BDCPP) and diphenyl phosph
130                                     Tris(1,3-dichloro-2-propyl) phosphate (TDCIPP) has been frequentl
131 oroisopropyl) phosphate (TCIPP), or tris(1,2-dichloro-2-propyl) phosphate (TDCIPP).
132 ate (DPP), metabolites of the OPFRs tris(1,3-dichloro-2-propyl) phosphate (TDCPP) and triphenyl phosp
133 )phosphate (TCIPP; max: 14500 ng/L), bis(1,3-dichloro-2-propyl)phosphate (BDCIPP; max: 4550 ng/L), tr
134  uptake and elimination of TDCPP and bis(1,3-dichloro-2-propyl)phosphate (BDCPP, the primary metaboli
135 magnitude concentration increase in tris(1,3-dichloro-2-propyl)phosphate (TDCIPP) and tri-m-cresyl ph
136  flame retardants (PFRs), including tris(1,3-dichloro-2-propyl)phosphate (TDCIPP) and triphenyl phosp
137 ncluded triphenyl phosphate (TPHP), tris(1,3-dichloro-2-propyl)phosphate (TDCIPP) and tris(2-chloroet
138                                     Tris(1,3-dichloro-2-propyl)phosphate (TDCIPP) is a high-productio
139                                     Tris(1,3-dichloro-2-propyl)phosphate (TDCIPP) is a high-productio
140 lhexyl) tetrabromophthalate (TBPH), tris(1,3-dichloro-2-propyl)phosphate (TDCIPP), and triphenyl phos
141 phosphate (BDCIPP; max: 4550 ng/L), tris(1,3-dichloro-2-propyl)phosphate (TDCIPP; max: 3150 ng/L) and
142 osphate flame retardants (ClOPFRs), tris(1,3-dichloro-2-propyl)phosphate (TDCPP or TDCIPP), tris(1-ch
143 ondensation of 2,5-dihydroxyquinone with 4,5-dichloro-, 2,6-dichloro-, and 4,5-dibromo-1,2-phenylened
144 d with equal potency to human COX-2 with 2,6-dichloro-, 2,6-dimethyl-, or 2-chloro-6-methyl-substitut
145  catechol metabolite, 4,5-di-OH-PCB 11 (3',5-dichloro-3,4-dihydroxybiphenyl), were unambiguously iden
146  polymerization (SSP) does not occur for 2,5-dichloro-3,4-ethylenedioxythiophene (DCEDOT), and requir
147 atalyzes a second hydroxylation, forming 2,6-dichloro-3,5-dihydroxybenzoic acid.
148 NH(2))(2)[M(2)L(3)] (M = Zn, Mn; H(2)L = 2,5-dichloro-3,6-dihydroxo-1,4-benzoquinone) undergo linker
149 pound, (Me2NH2)2[Fe2L3].2H2O.6DMF (LH2 = 2,5-dichloro-3,6-dihydroxo-1,4-benzoquinone) was previously
150 much less toxic dihydroxylation product, 2,5-dichloro-3,6-dihydroxy-1,4-benzoquinone (chloranilic aci
151 tion of the redox-active bridging ligand 2,5-dichloro-3,6-dihydroxy-1,4-benzoquinone (LH2) with Fe(II
152 SO(4))(2) (Cl(2) dhbq(n-) = deprotonated 2,5-dichloro-3,6-dihydroxybenzoquinone) (2-SO(4)), are shown
153 obenzoquinone and fully converted to the 2,5-dichloro-3-(indol-3-yl)benzoquinone targets by DDQ or Ag
154 xygenase BbdD transforming 2,6-DCBA into 2,6-dichloro-3-hydroxybenzoic acid.
155 TDF) the required intermediate, 3-[4-[1-(2,6-dichloro-3-iodo-4-trifluoromethylphenyl)-5-iodopyrazolo]
156 to form additional HBQs, such as TriCBQ, 2,6-dichloro-3-methyl-(1,4)benzoquinone (DCMBQ), and 2,3,5,6
157 ), 2,6-dichloro-1,4-benzoquinone (DCBQ), 2,6-dichloro-3-methyl-1,4-benzoquinone (DCMBQ), 2,3,6-trichl
158 2,3,6-trichloro-1,4-benzoquinone (TCBQ), 2,6-dichloro-3-methyl-1,4-benzoquinone (DCMBQ), and 2,6-dibr
159 2,3,6-trichloro-1,4-benzoquinone (TCBQ), 2,6-dichloro-3-methyl-1,4-benzoquinone (DCMBQ), and 2,6-dich
160 oquinone (OH-DCBQ) from DCBQ, 5-hydroxyl-2,6-dichloro-3-methyl-1,4-benzoquinone (OH-DCMBQ) from DCMBQ
161 trifluoromethyl-4-nitrophenol (TFM) and 2',5-dichloro-4'-nitrosalicylanilide (niclosamide) are direct
162          Analogues of penclomedine (PEN, 3,5-dichloro-4,6-dimethoxy-2-(trichloromethyl)pyridine) and
163 3)) and a non-liver-targeted TR agonist, 3,5-dichloro-4-(4-hydroxy-3-isopropylphenoxy)phenylacetic ac
164 is of the targeted 2-chloro- and 2-bromo-6,7-dichloro-4-(beta-d-ribofuranosyl)quinolines (18and 21, r
165         We proposed to synthesize 2-halo-6,7-dichloro-4-(beta-d-ribofuranosyl)quinolines as 6 + 6 bic
166  used structure-based design to discover 2,6-dichloro-4-cyanophenyl and (1R,2R)-2-fluorocyclopropylam
167 s prepared in 10 steps from pyrazole and 3,5-dichloro-4-fluorobenzotrifluoride.
168                         PEN and 4-DMPEN (3,5-dichloro-4-hydroxy-6-methoxy2-(trichloromethyl)pyridine
169 renylindole)tin in coupling with a bromo-2,5-dichloro-4-indolylbenzoquinone gives the demethylasterri
170 hanamine, was prepared by first coupling 2,5-dichloro-4-nitroaniline with 2-mercapto-N,N-dimethylbenz
171                                 3-[4-[1-(2,6-dichloro-4-trifluoromethylphenyl)pyrazolo]]-3-(trifluoro
172                  The structures of the bound dichloro (5) and dimethyl (12) analogue complexes indica
173 enes have been synthesized starting from 6,9-dichloro-5,10-diaza[5]helicene, which was prepared from
174 lization of 4-arylpent-4-enoic acid with 1,3-dichloro-5,5-dimethylhydantoin (DCDMH), is revealed to b
175              The use of a combination of 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) and beta-pin
176 hloromethane, followed by oxidation with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) generates a
177                                          2,3-Dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) is a highly
178 enes and isochromenes react quickly with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) to form pers
179 followed by oxidative aromatization with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone produced the funct
180 (2)Cl(2) followed by oxidation with DDQ (2,3-dichloro-5,6-dicyano-1,4-benzoquinone) and alumina colum
181 Q-mediated dehydrogenation reaction (DDQ=2,3-dichloro-5,6-dicyano-1,4-benzoquinone).
182  kinetics of the hydride abstractions by 2,3-dichloro-5,6-dicyano-p-benzoquinone (DDQ) from 13 C-H hy
183                             Reactions of 2,3-dichloro-5,6-dicyano-p-benzoquinone (DDQ) with silyl eno
184 t the sp-hybridized C2, with either DDQ (2,3-dichloro-5,6-dicyano-p-benzoquinone) or TBHP (tert-butyl
185         When the oxidant was replaced by 2,3-dichloro-5,6-dicyano-p-benzoquinone, which is frequently
186 with various styrenes in the presence of 2,3-dichloro-5,6-dicyanobenzoquinone (DDQ) was promoted by B
187 anyl azaBODIPY was in situ oxidized with 2,3-dichloro-5,6-dicyanobenzoquinone and either reacted with
188 FeCl(3), CuCl(2), [Co(NH(3))(5)Cl]Cl(2), 2,3-dichloro-5,6-dicyanobenzoquinone, or ceric ammonium nitr
189 of two target compounds, (RS)-2-amino-3-(3,4-dichloro-5-(5-hydroxypyridin-3-yl)phenyl)propanoic acid
190 e reaction of the commercially available 4,6-dichloro-5-aminopyrimidine 1 with isothiocyanates.
191 A highly selective monodechlorination of 2,6-dichloro-5-fluoronicotinic acid was discovered to afford
192 d 1 (SKI-606, bosutinib), a 7-alkoxy-4-[(2,4-dichloro-5-methoxyphenyl)amino]-3-quinolinecarbonitrile,
193                                        A 2,4-dichloro-5-methoxyphenylamino group at C-7 provided supe
194 he nucleophilic aromatic substitution of 4,6-dichloro-5-nitrobenzofuroxan 1 with eight aliphatic amin
195  photocycloaddition of crystalline trans-2,4-dichloro-6-styrylpyrimidine to produce the corresponding
196 racterization of one of these compounds, 2,4-dichloro-6-{(E)-[(3-methoxyphenyl)imino]methyl}phenol (D
197 l)[1,4]benzoquinone and 2,5-dihydroxy-3-(4,6-dichloro-7-farnesyl-1H-indol-3-yl)[1,4]benzoquinone, are
198 dro-2 H-pyran, an alcohol, and catalytic 1,5-dichloro-9,10-anthraquinone with use of visible light.
199 containing the fluorogenic substrate 9H-(1,3-dichloro-9,9-dimethylacridin-2-on-7-yl) beta-D-galactosi
200 te of beta-galactoside and 7-hydroxy-9H-(1,3-dichloro-9,9-dimethylacridin-2-one) (DDAO), is not only
201 aved by beta-gal to produce 7-hydroxy-9H(I,3-dichloro-9,9-dimethylacridin-2-one) (DDAO).
202 sulfatase-activated probe, 7-hydroxy-9H-(1,3-dichloro-9,9-dimethylacridin-2-one)-sulfate, that detect
203                       One substrate, 9H-(1,3-dichloro-9,9-dimethylacridin-2-one-7-yl) beta-d-galactop
204 ent substrate of beta-galactosidase (9H-{1,3-dichloro-9,9-dimethylacridin-2-one-7-yl} beta-D-galactop
205                                          2,6-Dichloro-9-thiabicyclo[3.3.1]nonane is especially useful
206               Herein we introduce 2-((3-(3,6-dichloro-9H-carbazol-9-yl)-2-hydroxypropyl)amino)-2-(hyd
207          Asymmetric hydration of alpha,alpha-dichloro aldehydes and alpha-halo enals via a NHC-cataly
208                                    The 2',5'-dichloro analogue 8 showed selectivity ratios (IC(50) ag
209                                          2,3-Dichloro- and 2,3-dibromopyridines have been shown to re
210 d and optimized to give 80-90% yields of 2,6-dichloro- and 2,6,7-trichloro-3-(2,3-dideoxy-2,3-didehyd
211                                              Dichloro- and phenylchlorocarbene (CCl2 and PhCCl) add t
212 s possible to conclude that at least 2 HAAs (dichloro- and trichloroacetic acids, DCAA and TCAA) are
213 nic matter (DOM) had no measurable effect on dichloro- and trichlorobiphenyls, but did contain about
214                2,4,5-Trichloro-, 2-bromo-4,5-dichloro-, and 2,4,5-tribromoimidazole nucleosides were
215 2,5-dihydroxyquinone with 4,5-dichloro-, 2,6-dichloro-, and 4,5-dibromo-1,2-phenylenediamine, followe
216 y with the dipole moments of chloro-, nitro- dichloro-, and dinitro- (o-, m-, and p-) benzene guests.
217  analogues (2-amino-benzimidazole and 1-(3,4-dichloro-benzyl)-2-amino-benzimidazole) in complex with
218 is of the alternative binding mode of 1-(3,4-dichloro-benzyl)-2-amino-benzimidazole, derivatives were
219 the bis-pyridinium derivative 4,4'-bis-[(2,6-dichloro-benzyloxy-imino)-methyl]-1,1'-propane-1,3-diyl-
220                The corresponding alpha,alpha-dichloro-beta-hydroxyketones were obtained by treatment
221 lization promoted by the 1:1 complex of o,o'-dichloro-BINOL and SbCl(5).
222 on on the oxygenated phenyl ring, e.g., 4,4'-dichloro-biphenyl-2,5-diol, 3,6,4'-trichloro-biphenyl-2,
223 repared, 6-chloro-biphenyl-3,4-diol and 6,4'-dichloro-biphenyl-3,4-diol.
224                              Reaction of the dichloro-bridged dimers [(C'N(2)Ir(mu-Cl)(2)Ir(C'N)(2)]
225 on battery system, the electrolyte is of the dichloro complex (DCC) solution family, Mg(AlCl2BuEt)2/T
226 Surprising differences were seen between the dichloro complex 2b with isopropyl groups on phosphorus,
227                                              Dichloro complexes (L(1) = L(2) = Cl, 2a-2c,2e) showed i
228  from ca. 20 pg/L (part-per-quadrillion) for dichloro-congeners down to ca. 0.2 pg/L for higher-molec
229    Log K(POM) values ranged from ca. 4.6 for dichloro-congeners to ca. 7.0 for octachloro-congeners a
230        Chlorination of anthracimycin gives a dichloro derivative that retains activity against Gram-p
231 tereomeric separation by substitution of the dichloro derivative with a chiral amine has been shown.
232 timicrobial activity and revealed simplified dichloro derivatives that are equally potent against sev
233 traphenylmetallole dianion and corresponding dichloro(dialkyl)silanes.
234 s as well as a fluorescent dye, carboxy-H(2)-dichloro-dihydrofluorescein diacetate (carboxy-H(2)-DCFD
235 and rhodizonic acids, dihydroxybenzoquinone, dichloro-dihydroxy-p-benzoquinone, or benzene decorated
236 sistance of these species to the insecticide dichloro-diphenyl-trichloroethane (DDT).
237 l- channel antagonists, niflumic acid (NFA), dichloro-diphenylamine 2-carboxylic acid (DCDPC) and dii
238                                          The dichloro form of the drug exists in equilibrium with at
239 ely converts the aquated species back to the dichloro form of the parent drug so that a single molecu
240 rect vinylogous aldol addition of alpha,beta-dichloro gamma-butyrolactones and gamma-butyrolactams wi
241 4]) > chloral hydrate (165% [161-176]) > 2,2-dichloro- > 2-chloro approximately 2,2,2-trifluoroethano
242                                          The dichloro(heteroaryl)borane primary products can be prote
243 zine privileged structures (2-methoxy vs 2,3-dichloro) influenced bias when the thienopyridine hetero
244 chloro-2-propyl) phosphate (BDCIPP)-tris(1,3-dichloro-isopropyl) phosphate (TDCIPP) and bis(2-chloroe
245 e additive flame retardants (FRs), tris (1,3-dichloro-isopropyl) phosphate (TDCPP) and Firemaster((R)
246                              The reaction of dichloro ketones with azide anions provides acyl azides,
247 ion of 7-chloro-L-tryptophan to generate 6,7-dichloro-L-tryptophan.
248 ntially on free L-tryptophan to generate 6,7-dichloro-L-tryptophan.
249 cts (water, methanol, ethyl acetate, hexane, dichloro-methane) of fenugreek seeds were investigated i
250   A second compound, NT-9-21, which contains dichloro moieties in place of the 3,5-dibromo substituen
251  therapy-specifically 2-quinoxalinamine, 6,7-dichloro-N-(1,1-dimethylethyl)-3-(methylsulfonyl)-,6,7-d
252                                      The 3,4-dichloro-N-(1-(dimethylamino)cyclohexyl)methyl benzamide
253 .08, or 0.16 mg/kg) and D2/D3 antagonist 3,5-dichloro-N-(1-ethylpyrrolidin-2-ylmethyl)-2-hydroxy-6-me
254  three most potent compounds: 918013 (1; 2,4-dichloro-N-(3-fluorophenyl)-5-(4-morpholinylsulfonyl) be
255 olus injections of 11C-raclopride (S-(-)-3,5-dichloro-N-[(1-ethyl-2-pyrrolidinyl)]methyl-2-hydroxy-6-
256                      Taking advantage of 3,5-dichloro-N-[1-(2,2-dimethyl-tetrahydro-pyran-4-ylmethyl)
257 ice and a panselective T-channel blocker 3,5-dichloro-N-[1-(2,2-dimethyltetrahydro-pyran-4-ylmethyl)-
258 t not by the kappa agonist trans-(1S,2S)-3,4-dichloro-N-mathyl-N-[2-(1-pyrrolidinyl)cyclohexyl]-benze
259 ,D-Leu5]-enkephalin (DADLE), trans-(+/-)-3,4-dichloro-N-methyl-N-(2-[1-pyrrolidinyl]cyclohexyl) benze
260 f this finding, the N-methylated analog, 2,5-dichloro-N-methyl-N-(2-methyl-4-nitrophenyl)benzenesulfo
261 nt with the kappa agonist U50,488 (trans-3,4-dichloro-N-methyl-N-[2-(1-pyrolytinil)-cyclohexyl]-benze
262 lic [D-Pen2-D-Pen5]-enkephalin, or trans-3,4-dichloro-N-methyl-N-[2-(1-pyrolytinil)-cyclohexyl]-benze
263  Treatment with the agonist (-)-(trans)-3,4- dichloro-N-methyl-N-[2-(1-pyrrolidiny)cyclohexyl]benzene
264  analgesic effect of the agonist (trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)-cyclohexyl] benz
265 -Pen(5)]-enkephalin (1 microm) and trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)-cyclohexyl]benze
266  of the KOR agonist U50,488 [(+/-)-trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]-benze
267 ersion caused by the kappa agonist trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]-benze
268  hydrochloride) and U50488H (trans-(+/-)-3,4-dichloro-N-methyl-N-[2-(pyrrolidinyl)cyclohexyl] benzene
269 infusion of the kappa-OR agonist (trans)-3,4-dichloro-N-methyl-N-[2-1-pyrrolidinyl)-cyclo-hexyl] benz
270 hemBridge, San Diego, CA; ID5128535) and 2,4-dichloro-N-{4-[(1,3-thiazol-2-ylamino)sulfonyl]phenyl}be
271                                          N,N-dichloro-o-nitrobenzenesulfonamide (2-NsNCl2) was found
272 flow reactor or nucleophilic substitution of dichloro (oxa)helicenes with alkanethiolates were used i
273 zes 2,4,5-trichlorophenol (2,4,5-TCP) to 2,5-dichloro-p-benzoquinone, which is chemically reduced to
274 1,4-diene, Bu3SnD, and pyridine.BD3 with 2,5-dichloro-p-benzoquinone.
275 oquinone, which is chemically reduced to 2,5-dichloro-p-hydroquinone (2,5-DiCHQ).
276 trichloro-p-hydroquinone (TriCH) and then to dichloro-p-hydroquinone (DiCH) in the PCP degradation pa
277                                    PcpA (2,6-dichloro-p-hydroquinone 1,2-dioxygenase) from Sphingobiu
278    It converted 2,4,5-trichlorophenol to 2,5-dichloro-p-quinol and then to 5-chlorohydroxyquinol but
279  converted 2,4,6-trichlorophenol only to 2,6-dichloro-p-quinol as the final product.
280 echanisms of the reactions of p-quinone, 2,5-dichloro-p-quinone, 2,3,4,5-tetrachloro-p-quinone (chlor
281   The reaction employs readily available N,N-dichloro-p-toluenesulfonamide (TsNCl(2)) and acetonitril
282 ulfonate, chlorodicarbonylrhodium (I) dimer, dichloro(pentamethylcylcopentadienyl)rhodium (III) dimer
283 es of 0.92 and 0.37 for 4-Cl-Ph-O-dG and 2,6-dichloro-Ph-O-dG (DCP-O-dG), respectively.
284  and sites of activator actions of 2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nico
285 igated the mechanisms of action of 2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nico
286 h [(3)H]SR141716A [5-(4-chlorophenyl)-1-(2,4-dichloro-phenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazo l
287 e 2 agonists such as PD-118057 [2-(4-[2-(3,4-dichloro-phenyl)-ethyl]-phenylamino)-benzoic acid] atten
288       One example is PD-118057 (2-{4-[2-(3,4-dichloro-phenyl)-ethyl]-phenylamino}-benzoic acid) which
289          Diaminocyclohexane(trans-diacetato)(dichloro) platinum(IV) (DAP), a platinum-based coordinat
290 vel alpha4beta2 NNR agonist (ABT-894 (3-(5,6-dichloro-pyridin-3-yl)-1(S),5 (S)-3,6-diazabicyclo[3.2.0
291                      The 1:1 complex of o,o'-dichloro-R-BINOL and SbCl5 initiates the enantioselectiv
292 esis more efficiently than the commonly used dichloro-ruthenium complexes, indicating that its utilit
293                Subsequent reduction of these dichloro-species afforded unprecedented four-membered gr
294 ying 2,6-difluoro, 2-chloro-6-fluoro, or 2,6-dichloro substituted benzyl moieties.
295  group, the mutations reduced binding of 2,4-dichloro-substituted compounds more than 4-chloro-substi
296 r 2-pyridylphenylamide and 2-methoxy- or 2,3-dichloro-substituted phenylpiperazines to measure the im
297 les in a doped quantum magnet (bromine-doped dichloro-tetrakis-thiourea-nickel, DTN).
298 le, 2, was synthesized from the reduction of dichloro(tetraphenyl)germole with 2 equivs of Li.
299 hium salts of tetraphenylsilole dianion with dichloro(tetraphenyl)germole.
300 itative calibration was simplified by adding dichloro- to hexachlorobiphenyl internal standards chose

 
Page Top